Dear Colleagues,
|
COVID-19 Cases: |
|
|
BMC Total Inpatients |
15 |
|
BMC Inpatients Requiring ICU Care |
4 |
|
Cumulative Staff Who Have Tested Positive |
2,891 (as of 2/21) |
|
Massachusetts Cases |
1,535,009 |
Click to see the most up-to-date city, state, and national numbers: Boston | Massachusetts | United States
REMINDER: BMC is Now in a Phase A for COVID-19 Response
BMC has moved from a Phase C to a Phase A for COVID response, as of Friday, February 18. This follows the rapid decline in COVID-19 cases throughout the region and the MA Department of Public Health downgrading hospitals from Tier 4 – Active Ongoing Constraints to Tier 3 – High Risk
Teams across the hospital will continue to monitor the situation and adjust our response as needed.
NEW: Changes to Lobby Screening Process
As of February 20, the screening process for patients and visitors has changed due to the decline in COVID cases. The screening process has now returned to the practices that were put in place in September 2021.
Each lobby entrance to the hospital will be staffed, but screeners will no longer check appointments and issue wristbands. Instead, everyone who comes into a BMC building will be given a mask, asked to sanitize their hands, and reminded that they should stay home if they are symptomatic or have been recently exposed to COVID-19. Patients will then be sent to their appointments, while visitors will be directed to the information desk for passes. Individual clinics will continue to ask patients about COVID-19 symptoms and exposure.
NEW: Changes to Cancer Center Visitor Policy
Beginning Thursday, February 24, one visitor will be permitted to accompany each patient in the Moakley 3rd floor hematology/oncology clinic and infusion center. This aligns the Cancer Center visitor policy with the visitor policy for all other Ambulatory areas.
No visitors will be allowed to accompany patients who currently have a confirmed COVID-19 diagnosis.